Medtronic, Aetna ink risk-sharing agreement

Dublin-based Medtronic, a medical technology provider, signed an outcomes-based agreement with Hartford, Conn.-based Aetna.

Under the agreement, part of Medtronic's reimbursement will be tied to clinical improvement measures to enhance care quality while lowering medical expenses. The outcomes-based model will affect Aetna members with type 1 and type 2 diabetes who transition to Medtronic's insulin pump from multiple daily injections.

Some Aetna policyholders will transfer to one Medtronic insulin system, called the MiniMed 670G, which continuously self-adjusts insulin amounts based on a patient's specific needs.  

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Top 40 articles from the past 6 months